|
| 36774856 | The safety profile of EGFR/ALK-TKIs administered immediately before or after ICIs in advanced NSCLC. | Int Immunopharmacol | 2023 |
| 36949340 | Curcumin protects against doxorubicin induced oxidative stress by regulating the Keap1-Nrf2-ARE and autophagy signaling pathways. | Psychopharmacology (Berl) | 2023 |
| 36587500 | Advances in pharmacokinetics and pharmacodynamics of PD-1/PD-L1 inhibitors. | Int Immunopharmacol | 2023 |
| 34648945 | Lung Cancer Driven by BRAF<sup>G469V</sup> Mutation Is Targetable by EGFR Kinase Inhibitors. | J Thorac Oncol | 2022 |
| 35734411 | Recent Advancements of Monotherapy, Combination, and Sequential Treatment of EGFR/ALK-TKIs and ICIs in Non-Small Cell Lung Cancer. | Front Pharmacol | 2022 |
| 35574406 | <i>CDC25C</i> as a Predictive Biomarker for Immune Checkpoint Inhibitors in Patients With Lung Adenocarcinoma. | Front Oncol | 2022 |
| 35756539 | Inflammatory response of gut, spleen, and liver in mice induced by orally administered <i>Porphyromonas gingivalis</i>. | J Oral Microbiol | 2022 |
| 36426352 | Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma. | Front Immunol | 2022 |
| 35990690 | Features of patients with advanced EGFR-mutated non-small cell lung cancer benefiting from immune checkpoint inhibitors. | Front Immunol | 2022 |
| 34648945 | Lung Cancer Driven by BRAF<sup>G469V</sup> Mutation Is Targetable by EGFR Kinase Inhibitors. | J Thorac Oncol | 2022 |
| 32457635 | Polymorphisms of Drug-Metabolizing Enzymes and Transporters Contribute to the Individual Variations of Erlotinib Steady State Trough Concentration, Treatment Outcomes, and Adverse Reactions in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Patients. | Front Pharmacol | 2020 |
| 31694835 | Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer. | Clin Cancer Res | 2020 |
| 32010279 | Involvement of neurotrophic signaling in doxorubicin-induced cardiotoxicity. | Exp Ther Med | 2020 |
| 33014280 | Curcumin Attenuates Chronic Unpredictable Mild Stress-Induced Depressive-Like Behaviors via Restoring Changes in Oxidative Stress and the Activation of Nrf2 Signaling Pathway in Rats. | Oxid Med Cell Longev | 2020 |
| 32673448 | Exosome-transmitted linc00852 associated with receptor tyrosine kinase AXL dysregulates the proliferation and invasion of osteosarcoma. | Cancer Med | 2020 |
| 32494183 | Salvianolic Acid B Improves Chronic Mild Stress-Induced Depressive Behaviors in Rats: Involvement of AMPK/SIRT1 Signaling Pathway. | J Inflamm Res | 2020 |
| 31115560 | Effects of miRâ¿¿181a on the biological function of multiple myeloma. | Oncol Rep | 2019 |
| 29196964 | The earlier, the better: the effects of different administration timepoints of sorafenib in suppressing the carcinogenesis of VEGF in rats. | Cancer Chemother Pharmacol | 2018 |
| 30039303 | Correlation of plasma erlotinib trough concentration with skin rash in Chinese NSCLC patients harboring exon 19 deletion mutation. | Cancer Chemother Pharmacol | 2018 |
| 30170425 | The expression and role of miR-181a in multiple myeloma. | Medicine (Baltimore) | 2018 |
| 29361914 | Testes-specific protease 50 (TSP50) promotes invasion and metastasis by inducing EMT in gastric cancer. | BMC Cancer | 2018 |
| 27750381 | Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors. | Int J Cancer | 2017 |
| 28193228 | MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression. | J Exp Clin Cancer Res | 2017 |
| 28157070 | Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis⿩. | Int J Clin Pharmacol Ther | 2017 |
| 28642170 | lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition. | Cancer Lett | 2017 |
| 27612448 | Primary rare anaplastic large cell lymphoma, ALK positive in small intestine: case report and review of the literature. | Diagn Pathol | 2016 |
| 27672238 | TBL1XR1 Is Highly Expressed in Gastric Cancer and Predicts Poor Prognosis. | Dis Markers | 2016 |
| 25310512 | Vascular endothelial growth factor accelerates establishment of a model of hepatic metastasis in Walker-256 tumor-bearing rats. | Am J Med Sci | 2015 |
| 26124487 | Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma. | J Clin Oncol | 2015 |
| 25609067 | Integrating RAS status into prognostic signatures for adenocarcinomas of the lung. | Clin Cancer Res | 2015 |
| 24251405 | Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma. | Histopathology | 2014 |
| 25674229 | Undifferentiated embryonal sarcoma of liver: a multi-institutional experience with 9 cases. | Int J Clin Exp Pathol | 2014 |
| 25183396 | Primary spleen extranodal NK/T cell lymphoma, nasal type, with bone marrow involvement and CD30 positive expression: a case report and literature review. | Diagn Pathol | 2014 |
| 24799889 | Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer. | Gastroenterol Res Pract | 2014 |
| 24649939 | A gangliocytic patially glandular paraganglioma with lymph node metastasis. | Diagn Pathol | 2014 |
| 24305008 | Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients. | J Thorac Oncol | 2014 |
| 23443783 | [Prediction and identification of B-cell linear epitopes of hepatitis B e antigen]. | Nan Fang Yi Ke Da Xue Xue Bao | 2013 |
| 23866935 | Renal collecting duct carcinoma with extensive coagulative necrosis mimicking anemic infarct: report of a case and the literature review. | Diagn Pathol | 2013 |
| 22237259 | Pharmacogenetic analysis of BR.21, a placebo-controlled randomized phase III clinical trial of erlotinib in advanced non-small cell lung cancer. | J Thorac Oncol | 2012 |
| 22699056 | [Expression of TMEM16A in gastric carcinoma and its clinical implications]. | Nan Fang Yi Ke Da Xue Xue Bao | 2012 |
| 22539604 | Association of the 15q25 and 5p15 lung cancer susceptibility regions with gene expression in lung tumor tissue. | Cancer Epidemiol Biomarkers Prev | 2012 |
| 22275131 | The use of FTA cards for preserving unfixed cytological material for high-throughput molecular analysis. | Cancer Cytopathol | 2012 |
| 21187439 | In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. | J Immunol | 2011 |
| 21107284 | Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer. | J Thorac Oncol | 2011 |
| 21041478 | Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer. | Mol Cell Biol | 2011 |
| 21258416 | TAZ is a novel oncogene in non-small cell lung cancer. | Oncogene | 2011 |
| 20739434 | Prognostic gene expression signature for squamous cell carcinoma of lung. | Clin Cancer Res | 2010 |
| 21240995 | Detection of EGFR and KRAS mutations in fine-needle aspirates stored on Whatman FTA cards: is this the tool for biobanking cytological samples in the molecular era? | Cancer Cytopathol | 2010 |
| 20823422 | Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. | J Clin Oncol | 2010 |
| 19196983 | Prognostic gene signatures for non-small-cell lung cancer. | Proc Natl Acad Sci U S A | 2009 |